Ikarian Capital, LLC - 31 Jan 2026 SCHEDULE 13G/A Report for Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX)

Filing Manager
Ikarian Capital, LLC
Reporting Manager
Ikarian Capital, LLC
Security
Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share
Symbol
QNRX
Shares outstanding
1,678,873 shares
Disclosed Ownership
211,538 shares
Ownership
13%
Form type
SCHEDULE 13G/A
Filing time
06 Feb 2026, 17:28:48 UTC
Date of event
31 Jan 2026
Previous filing
15 Dec 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Ikarian Capital, LLC 13% 211,538 0 211,538 /s/ Neil Shahrestani Neil Shahrestani, Sole Manager
Neil Shahrestani 13% 211,538 0 211,538 /s/ Neil Shahrestani Neil Shahrestani